NCT03409211View on ClinicalTrials.gov

Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
PsoriasisPsoriatic Arthritis
Interventions
DIETARY_SUPPLEMENT

PEVCO

All subjects will receive PEVCO for 6 more weeks.

DIETARY_SUPPLEMENT

Dietary Supplement Capsules without Coconut Oil

All subjects will receive placebo (PBO) for 3 weeks

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03409211 - Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis | Biotech Hunter | Biotech Hunter